Phathom Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Phathom Pharmaceuticals

10/08/2023 14:57

* Phathom Pharmaceuticals Inc  PHAT.OQ  reported a quarterly
adjusted loss of $84.00​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 98 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Phathom Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of $84.00​.
    * The mean earnings estimate of analysts had risen by
about 9.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Phathom Pharmaceuticals Inc shares had risen by 5.7% this
quarter and gained 34.8% so far this year.
    * The company reported a quarterly loss of $40.97 million.
    * Wall Street's median 12-month price target for Phathom
Pharmaceuticals Inc is $21.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:57 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.98          -84.00         Missed
 Mar. 31 2023      -1.26          -0.89          Beat
 Dec. 31 2022      -1.35          -1.33          Beat
 Sep. 30 2022      -1.32          -1.32          Met